Видео ютуба по тегу Improving Car-T Outcomes

Opportunities to improve CAR-T outcomes
Opportunities to improve CAR-T outcomes
Associate Professor Jane Oliaro's Research Improving CAR-T Cell Therapy Outcomes
Associate Professor Jane Oliaro's Research Improving CAR-T Cell Therapy Outcomes
Improving treatment outcomes of CAR T-cell therapy
Improving treatment outcomes of CAR T-cell therapy
Strategies to improve CAR-T outcomes in patients with LBCL
Strategies to improve CAR-T outcomes in patients with LBCL
Identifying patient subgroups to improve outcome, resistance and toxicity in CAR T
Identifying patient subgroups to improve outcome, resistance and toxicity in CAR T
The potential of combination therapies to improve CAR-T outcomes in patients with CLL
The potential of combination therapies to improve CAR-T outcomes in patients with CLL
Improving survival outcomes and optimizing CAR-T therapy in patients with DLBCL
Improving survival outcomes and optimizing CAR-T therapy in patients with DLBCL
Relapsed/Refractory B-cell Lymphomas in the CAR-T Era: Improving Outcomes in a Population at Need
Relapsed/Refractory B-cell Lymphomas in the CAR-T Era: Improving Outcomes in a Population at Need
Can CD30 CAR T-cell consolidation improve outcomes after ASCT for patients with CD30+ lymphomas?
Can CD30 CAR T-cell consolidation improve outcomes after ASCT for patients with CD30+ lymphomas?
Improving toxicity and outcomes by taking ibrutinib during and after CAR T-cell therapy
Improving toxicity and outcomes by taking ibrutinib during and after CAR T-cell therapy
Intermittent neutrophil recovery associated with improved CAR-T outcomes in R/R LBCL
Intermittent neutrophil recovery associated with improved CAR-T outcomes in R/R LBCL
The Impact of Gut Microbiome on Transplant or CAR T-cell Therapy
The Impact of Gut Microbiome on Transplant or CAR T-cell Therapy
The potential of CAR-T to improve the outcomes of patients with high-risk myeloma
The potential of CAR-T to improve the outcomes of patients with high-risk myeloma
KEY NOTE LECTURE: SESSION III - Improving outcomes of therapy with CAR T cells
KEY NOTE LECTURE: SESSION III - Improving outcomes of therapy with CAR T cells
Increasing Epitope Spreading to Improve CAR T Therapy for Solid Tumors
Increasing Epitope Spreading to Improve CAR T Therapy for Solid Tumors
Enhancing outcomes of patients with DLBCL treated with CAR T-cell therapy
Enhancing outcomes of patients with DLBCL treated with CAR T-cell therapy
Summit Speaker Series: Developing better CAR T-Cell Therapies
Summit Speaker Series: Developing better CAR T-Cell Therapies
Real World Outcomes of CAR T Therapy – Experiences from Different Continents
Real World Outcomes of CAR T Therapy – Experiences from Different Continents
What strategies are being explored to improve CAR-T cell therapy? #myeloma
What strategies are being explored to improve CAR-T cell therapy? #myeloma
Jae Hong Park, MD: Improving Outcomes, Minimizing Toxicity With CAR T-Cell Therapy in B-Cell ALL
Jae Hong Park, MD: Improving Outcomes, Minimizing Toxicity With CAR T-Cell Therapy in B-Cell ALL